Connect with us

Market

Big Movers: Ascendis Pharma A/S (NASDAQ:ASND), Bed, Bath & Beyond (NASDAQ:BBBY)

Published

on

Thinly traded Ascendis Pharma A/S (NASDAQ:ASND) is up 56% premarket on increased volume in response to positive results from a Phase 3 clinical trial, heiGHt, evaluating once-weekly TransCon Growth Hormone in children with pediatric growth hormone deficiency (GHD).

The study met the primary endpoint demonstrating superiority to daily TransCon in terms of annualized height velocity (AHV) at week 52. Specifically, the treatment difference was 0.86 cm/year, a statistically significant result (p=0.0088). Also, the separation was statistically valid from week 26 onward.

Have you seen the article Forbes wrote about the ASDN Flying Passenger Drone and its technology?

The safety profile was on par with the daily regimen.

Weekly dosing is a major advantage since GHD patients need therapy over a period of years.

The data will be presented at ENDO 2019 on March 24.

Topline data from a second Phase 3, fliGHt, should be available next quarter. The company expects to file a U.S. marketing application in H1 2020.

Management will host a conference call this morning at 8:00 am ET to discuss the results.
Bed, Bath & Beyond (NASDAQ:BBBY) drifts lower after a Monday morning downgrade from Barclays to an Underweight rating from Equal Weight.

Why Investors Are Calling ASDN the BBBY of the Sky!

The investment firm isn’t seeing signs of a turnaround by BBBY. “It will be highly difficult for the company to build a home furnishing/decor business, which appears to be a critical factor in the ultimate success of a turnaround,” warns analyst Matthew McClintock.

Shares of Bed Bath & Beyond are down 2.94% in premarket trading to $16.20 vs. a 52-week trading range of $10.46 to $23.28.

Continue Reading

Market

ConforMIS Inc (NASDAQ: CFMS): Premium Members Made A Quick 65% Profit In Just 1 week

Published

on

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/
JOIN US NOW: For Details Contact us at info@tradersinsights.com

Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy ConforMIS Inc (NASDAQ: CFMS) yesterday (march 13th) at $1.36. Now look at the price of the stock – its up 65% at $2.25 from our buy price. This is how easy money they made. If you had invested $5,000 in CFMS, it could had been moved up to $8,250. It’s not yet late, join us at info@tradersinsights.com

Continue Reading

Market

Rockwell Medical Inc (NASDAQ: RMTI): Premium Members Made A Quick 20% Profit In 24 Hours

Published

on

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/
JOIN US NOW: For Details Contact us at info@tradersinsights.com

Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy Rockwell Medical Inc (NASDAQ: RMTI) yesterday (march 18th) at $5.42. Now look at the price of the stock – its up 20% at $6.55 from our buy price. This is how easy money they made. If you had invested $5,000 in RMTI, it could had been moved up to $6,000. It’s not yet late, join us at info@tradersinsights.com

Continue Reading

Market

Sorrento Therapeutics Inc (NASDAQ: SRNE): Members Made A Hefty 15% Profit In 24 Hours

Published

on

By

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/

 JOIN US NOW: For Details Contact us at info@tradersinsights.com

 Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy Sorrento Therapeutics Inc (NASDAQ: SRNE) yesterday (march 18th) at $2.67. Now look at the price of the stock – its up 15% at $3.23 from our buy price. This is how easy money they made. If you had invested $5,000 in SRNE, it could had been moved up to $5,750.  It’s not yet late, join us at info@tradersinsights.com

Continue Reading
Advertisement

Trending